Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. LNK International, Inc.
WARNING LETTER
•LNK International, Inc.•February 8, 2019

LNK International, Inc. – FDA Warning Letter, Feb 8, 2019

Record Details

The FDA inspected LNK International, Inc.'s drug manufacturing facility from January 23 to February 8, 2019, identifying significant CGMP violations, rendering their drug products adulterated.

Violations include: 1. **Failure to thoroughly investigate discrepancies (21 CFR 211.192):** Four lots of Diphenhydramine 50 mg Berry Syrup were released despite initial out-of-specification (OOS) microbial counts (TAMC and TCYMC). The firm's investigation confirmed OOS results but released lots based on additional samples, failing to adequately address contamination or its hazards. A recall of four lots due to microbial contamination was acknowledged. * **Required Actions:** Retrospective, independent review of all invalidated OOS results, comprehensive assessment of manufacturing operations for microbiological hazards, detailed risk assessment for distributed contaminated products, complete investigations into all lots with potential microbial contamination, and a comprehensive remediation plan for OOS investigation systems and overall deviation/discrepancy investigation systems.

2. **Failure to establish adequate laboratory controls (21 CFR 211.160(b)):** The firm lacked sufficient specifications and analytical testing procedures for critical quality attributes, including dissolution and 4-Aminophenol impurity testing for acetaminophen-containing drug products. * **Required Actions:** Provide a list of all chemical and microbial test methods/specifications, an assessment to ensure complete specifications

Company
LNK International, Inc.
Inspection date
February 8, 2019
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations I
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · 728fa12b-072c-4c33-948e-9f9cbfa13eec

Violation Codes6
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.160(b)21 CFR 211.34

Full citation text and observation details available on the Dashboard.

Other documents for LNK International, Inc.
  • 483 - 2025-10-28October 28, 2025
  • 483 - 2022-12-13December 13, 2022
  • EIR - 2021-07-01July 1, 2021
  • 483 - 2021-07-01July 1, 2021
  • 483 - 2019-02-08February 8, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore LNK International, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.